See also this year's filing and all EDGAR filings for this company.
PDF Report 0001347242_2025_Lipella_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001347242, Lipella Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,617,252 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,864 |
| 3 | remainder_Assets | 46,754 |
| 4 | LiabilitiesCurrent | 754,417 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,003,712 |
| 9 | ResearchAndDevelopmentExpense | 3,613,187 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 536,357 |
| 12 | remainder_NetIncome | 64,278 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,673,870 |
| 1 | Liabilities | 754,417 |
| 2 | Expenses | 5,616,899 |
| 3 | Revenues | 536,357 |
| 4 | StockholdersEquity | 1,919,453 |
| 5 | NetIncome | -5,016,264 |
| 6 | ComprehensiveNetIncome | -5,016,264 |
| 7 | BaseVar | 4,822,910 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.485 |
| 9 | EconomicCapitalRatio | 1.38 |
Edgar->Model Mapping
Feature Distribution
Change over Time
